Evelo Biosciences, Inc. Common Stock
EVLO
EVLO was delisted on the 11th of December, 2023.
49 hedge funds and large institutions have $508M invested in Evelo Biosciences, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 8 reducing their positions, and 8 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 8
141% more capital invested
Capital invested by funds: $211M → $508M (+$298M)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
13% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 8
2% more funds holding
Funds holding: 48 → 49 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.1M |
| 2 |
BlackRock
New York
|
+$2.24M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.65M |
| 4 |
AG
Artal Group
Luxembourg
|
+$1.39M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$1.21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$6.85M |
| 2 |
Millennium Management
New York
|
-$694K |
| 3 |
CCM
CAAS Capital Management
New York
|
-$173K |
| 4 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$158K |
| 5 |
Renaissance Technologies
New York
|
-$151K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CCM
51
CAAS Capital Management
New York
| – | -$173K | -1,637 | Closed |
|
|
52
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
| – | -$158K | -1,500 | Closed |
|
|
53
Renaissance Technologies
New York
| – | -$151K | -1,434 | Closed |
|
54
Jacobs Levy Equity Management
Florham Park,
New Jersey
| – | -$116K | -1,099 | Closed |
|
55
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$62K | -593 | Closed |
|
56
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$56K | -527 | Closed |
|
|
SO
57
STRS Ohio
Columbus,
Ohio
| – | -$8K | -80 | Closed |
|
EVLO Hedge Fund Activity: Q4 2020 in Review
49 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Evelo Biosciences, Inc. Common Stock (EVLO) for Q4 2020, worth a combined $508M — up 141% from $211M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new EVLO positions and 8 closed out — a net gain of 1 holder — while 24 added to existing stakes and 8 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $11.1M. The largest seller was BVF Inc, exiting entirely with an estimated $6.85M sold.
- 49 institutional investors held Evelo Biosciences, Inc. Common Stock (EVLO) as of Q4 2020, up from 48 in Q3 2020.
- Funds reported $508M of Evelo Biosciences, Inc. Common Stock stock for Q4 2020, up 141% quarter-over-quarter.
- 9 funds opened new Evelo Biosciences, Inc. Common Stock positions in Q4 2020 and 8 closed out, a net change of +1 holder.
- The largest Evelo Biosciences, Inc. Common Stock buyer in Q4 2020 was Fidelity Investments, an estimated $11.1M added.
- The largest Evelo Biosciences, Inc. Common Stock seller in Q4 2020 was BVF Inc, an estimated $6.85M sold.
Based on aggregated 13F filings for Q4 2020.